About this trial
Spinal cord associative plasticity (SCAP) is a combined cortical and spinal electrical stimulation technique developed to induce recovery of arm and hand function in spinal cord injury.
The proposed study will advance understanding of SCAP, which is critical to its effective translation to human therapy. The purpose of the study is to:
1. Determine whether signaling through the spinal cord to the muscles can be strengthened by electrical stimulation. 2. Improve our understanding of the spinal cord and how it produces movement. 3. Determine whether spinal surgery to relieve pressure on the spinal cord can improve its function.
Aim 1 is designed to advance mechanistic understanding of spinal cord associative plasticity (SCAP).
Aim 2 will determine whether SCAP increases spinal cord excitability after the period of repetitive pairing. In rats, SCAP augments muscle activation for hours after just 5 minutes of paired stimuli.
Whereas Aims 1 and 2 focused on the effects of paired stimulation in the context of uninjured spinal cord, Aim 3 assesses whether paired stimulation can be effective across injured cord segments. Aim 3 will incorporate the experiments from Aim 1 and 2 but in people with SCI, either traumatic or pre-operative patients with myelopathy in non-invasive experiments, or targeting myelopathic segments in intraoperative segments.
Eligibility criteria
Qualifiers
Age between 18-80 years.
Must have stable prescription medication for 30 days prior to screening
Must be able to: abstain from alcohol, smoking and caffeine consumption on the day of each experiment; abstain from recreational drugs for the entirety of the study; commit to study requirements (i.e., 7 visits); provide informed consent.
No known central or peripheral neurological disease or injury.
Disqualifiers
Personal or extensive family history of seizures;
Ventilator dependence or patent tracheostomy site;
Use of medications that significantly lower seizure threshold, such as amphetamines, neuroleptics, dalfampridine, and bupropion;
History of stroke, brain tumor, brain abscess, or multiple sclerosis;
Trial design
Treatments tested in this trial
- Non-invasive pairing of cortical and spinal stimulation
- Intraoperative pairing of cortical and spinal stimulation
- Non-invasive repeated pairing of cortical and spinal stimulation (SCAP)
- Intraoperative repeated pairing of cortical and spinal stimulation (SCAP)
- Intraoperative repeated pairing of cortical and spinal stimulation (SCAP) at or below myelopathic region
Treatment groups
Sponsors and collaborators
Columbia University
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
Weill Medical College of Cornell University
Collaborator
Bronx Veterans Medical Research Foundation, Inc
Collaborator